fbpx
Skip to content
CovidMD Telehealth App
  • About Shared Harvest
  • Board Members
  • CDC News
  • Donate

Johnson & Johnson Vaccine is 66% Effective in Preventing Moderate To Severe COVID-19

February 2, 2021
The COVID-19 vaccination was studied in 44,000 people and was found to prevent COVID in 72% in the US, 66% in Latin America, and 57% in South Africa. These findings…
Read More

A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines

January 16, 2021
Two vaccines have been approved for distribution in the U.S. The two have been shown to be equally (and highly) effictive across different ethnic and racial groups. Both require two…
Read More

Moderna says COVID-19 vaccine immunity to stay at least one year

January 16, 2021
Moderna states their mRNA vaccination should provide immunity that will last at least 1 year. The company also states that the mRNA in their vaccine will be effective against the…
Read More

6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study

January 16, 2021
While long term health consequences of COVID-19 remain largely unclear, a new study aims to pinpoint long term effects. In patients who were hospitalized with COVID-19, it has been found…
Read More
Search for:

Recent Posts

  • Johnson & Johnson Vaccine is 66% Effective in Preventing Moderate To Severe COVID-19
  • A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines
  • Moderna says COVID-19 vaccine immunity to stay at least one year
  • 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study
Copyright 2021 — CovidMD Telehealth App, Shared Harvest Foundation 501 (3) (c). All rights reserved.
Scroll to Top